<DOC>
	<DOCNO>NCT01021761</DOCNO>
	<brief_summary>Approximately 126 subject schedule undergo cataract surgery phacoemulsification , randomize even allocation ( 1:1:1 ) either Acuvail , Xibrom Nevanac . Subjects instruct begin dose study medication operative eye day surgery continue dose day surgery . Beginning one hour surgery 1 drop study medication instill operating room staff approximately every 15 minute total 3 dos . At designated time paracentesis perform start cataract procedure least 0.15cc aqueous humor collect . The sample immediately store dry ice ship laboratory analysis .</brief_summary>
	<brief_title>A Comparison Prostaglandin E2 ( PGE2 ) Inhibition Acuvail ( Ketorolac 0.45 % ) , Xibrom ( Bromfenac 0.09 % ) Nevanac ( Nepafenac ) Patients Undergoing Phacoemulsification</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<mesh_term>Dinoprostone</mesh_term>
	<criteria>Subjects must 18 year age old Scheduled cataract surgery phacoemulsification Subjects must willing comply study requirement willing give inform consent Any subject history uveitis active iritis Subject previous eye surgery exception refractive surgery within 6 month No ocular use prostaglandin within 2 week surgery Use oral , injectable topical ophthalmic steroid , NSAIDs immunosuppressant within 14 day prior surgery Contraindications nonsteroidal antiinflammatory drug ( NSAIDs ) Active ocular infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>